3048 Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices 

telephone interview process with key 

National Partners familiar with the 

CPHP program. The categories of 

questions will be similar to the CPHP 

Interview Instrument to gather 

information from the perspective of 

National Partners. The CPHP State and 

Local Partner/Customer Survey 

Instrument will be used to gather 

information from representatives of 

organizations that have received 

training or technical assistance from the 

CPHP Program. It will be administered 

electronically with an option for paper 

copy administration. It is estimated that 

there will be one request per respondent 

and a total of 135 respondents with an 

estimated time for data collection of 30 

minutes. The CPHP Partner/Customer 

Interview Instrument will be used to 

gather more in-depth information on the 

same categories of questions from the 

Survey Instrument. It is estimated that 

there will be a total of 54 respondents 

with an estimated time for data 

collection of 30 minutes. 

There are no costs to respondents 

except their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

(in hours) 

Pre-CPHP Interview Document Collection Protocol—CPHP staff .. 27 1 2 54 

(2) CPHP Interview Instrument—CPHP staff .................................. 54 1 2 108 

(3) CPHP National Partner Interview Instrument ............................ 10 1 2 20 

(4) CPHP State and Local Partner/Customer Survey Instrument ... 135 1 30/60 68 

(5) CPHP State and Local Partner/Customer Interview Instrument 54 1 30/60 27 

Total .......................................................................................................................................................................................... 277 

Dated: January 8, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–889 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day–09–09AL] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–5960 and 

send comments to Maryam I. Daneshvar, 

CDC Acting Reports Clearance Officer, 

1600 Clifton Road, MS-D74, Atlanta, GA 

30333 or send an e-mail to 

omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

The Green Housing Study—New— 

National Center for Environmental 

Health (NCEH), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

Green building principles and 

practices have been shown to reduce 

energy consumption, but their efficacy 

in reducing environmental agents such 

as pesticides, volatile organic 

compounds (VOCs), fungi, and indoor 

allergens is not clear. Furthermore, little 

research has been conducted on health 

impacts that might be related to green 

buildings, especially on a nationwide 

scale. Three main goals of this study are: 

(1) To compare levels of certain 

environmental chemical and biological 

agents in green vs. traditional, multifamily, low-income housing; (2) to 

ascertain differences in the health of the 

residents in these homes; and (3) to 

assess the economic impacts of the 

‘‘greening’’ of housing-particularly those 

related to health. These goals will be 

accomplished in an ongoing building 

renovation program, ‘‘Mark-to-Market’’ 

(M2M), sponsored by the Department of 

Housing and Urban Development 

(HUD). Briefly, the M2M program is a 

nationwide initiative that encourages 

owners and purchasers of affordable, 

multi-family properties to rehabilitate 

and operate their properties using 

sustainable green building principles. In 

partnership with HUD, the CDC will 

leverage this opportunity to collect 

survey and biomarker data from 

residents and to collect environmental 

measurements in their homes in order to 

evaluate associations between green 

housing and health. 

This study directly supports the 

Healthy Homes’ health protection goal 

of the Centers for Disease Control and 

Prevention (CDC). This investigation is 

also consistent with CDC’s Health 

Protection Research Agenda, which 

calls for research to identify the major 

environmental causes of disease and 

disability and related risk factors. 

Indoor allergens such as those from 

cockroaches, dust mites, mice, and fungi 

have been associated with childhood 

asthma. Also, VOCs and pesticides have 

been associated with adverse birth 

outcomes (e.g., low birth weight and 

prematurity) and delayed 

neurodevelopment. Given that green 

principles such as improvement of 

ventilation systems and elimination of 

spray pesticides can directly affect the 

concentrations of chemical and 

biological agents in air, residents in 

green housing should theoretically have 

better health outcomes (e.g., asthma, 

birth outcomes, and infant 

neurodevelopment, this in turn will 

lead to lower healthcare utilization and 

overall societal costs. 

Participants will include pregnant 

women, mothers and children living in 

mstockstill on PROD1PC66 with NOTICES

Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices 3049 

HUD-subsidized housing that has either 

been rehabilitated in a green (e.g., case) 

or a traditional manner (e.g., control) 

from study sites across the United 

States. Pregnant women and children 

with asthma (ages 7–12 years) will 

donate blood samples (for assessment of 

allergy) and urine samples (for 

assessment of pesticide and VOC 

exposures). The children with asthma 

(ages 7–12 years) will be also tested for 

lung function and lung inflammatory 

markers. Questionnaires regarding home 

characteristics and respiratory 

symptoms will be administered at 3- 

month intervals over a 2-year period. Of 

the pregnant women enrolled, 

neurodevelopment of their infant will 

be tested at ages 1 week and 6 months. 

Environmental sampling of the air and 

dust in the participants’ homes will be 

conducted over a 2 year period (once in 

the home before rehabilitation, and then 

at four time points after rehabilitation 

has been completed: Baseline, 6 months, 

12 months, and 24 months). 

Environmental sampling includes 

measurements of air exchange rate, 

pesticides, VOCs, indoor allergens, 

fungi, temperature, humidity, and 

particulate matter. 

There is no cost to respondents other 

than their time. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Forms Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response 

(in hours) 

Total burden 

(in hours) 

Mothers of enrolled 

children.

Screening questionnaire ............................ 800 1 5/60 067 

Baseline Questionnaire (Home Characteristics).688 1 15/60 172 

Baseline Questionnaire (for Mother) ......... 688 1 15/60 172 

Baseline Questionnaire (for Children 0–6 

years).

688 1 15/60 172 

Baseline Questionnaire (for Children 7–12 

with asthma).

688 1 15/60 172 

3, 9, 15, and 18-month Phone contact ..... 688 4 5/60 229 

6, 12, and 24-month Follow-up Questionnaire (for environment).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for women).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for children 0–6).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for asthmatic child 7–12).688 3 10/60 344 

Pregnant women ..... Screening questionnaire ............................ 800 1 5/60 67 

Baseline Questionnaire (Home Characteristics).688 1 15/60 172 

Baseline Questionnaire (for Pregnant 

woman).

688 1 15/60 172 

3, 9, 15, and 18-month Phone contact ..... 688 4 5/60 229 

6, 12, and 24-month Follow-up Questionnaire (for environment).688 3 10/60 344 

6, 12, and 24-month Follow-up Questionnaire (for women).688 3 10/60 344 

Post-delivery questionnaire ....................... 688 1 5/60 57 

Total .......................................................................................................................................................................................... 3745 

Dated: January 8, 2009. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E9–890 Filed 1–15–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Member 

Conflict Review, Program 

Announcement (PA) 07–318 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1 p.m.–3 p.m., March 5, 

2009 (Closed). 

Place: National Institute for Occupational 

Safety and Health (NIOSH), CDC, 1095 

Willowdale Road, Morgantown, West 

Virginia 26506, telephone: (304) 285–6143. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘Member Conflict Review, PA 

07–318.’’ 

Contact Person for More Information: Chris 

Langub, PhD, Scientific Review Official, 

NIOSH, CDC, 2400 Century Center, Atlanta, 

GA 30333, telephone: (404) 498–2543. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

mstockstill on PROD1PC66 with NOTICES